328 related articles for article (PubMed ID: 16389729)
21. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
Schmidt HD; Duman RS
Behav Pharmacol; 2007 Sep; 18(5-6):391-418. PubMed ID: 17762509
[TBL] [Abstract][Full Text] [Related]
22. [Affective disorders and antidepressant drugs: Therapeutic innovations].
Fakra E; Azorin JM; Adida M; Da Fonseca D; Kaladjian A; Pringuey D
Encephale; 2010 Dec; 36 Suppl 6():S183-7. PubMed ID: 21237354
[TBL] [Abstract][Full Text] [Related]
23. New understanding of mechanisms of action of bipolar medications.
Sanacora G
J Clin Psychiatry; 2008; 69 Suppl 5():22-7. PubMed ID: 19265637
[TBL] [Abstract][Full Text] [Related]
24. Cognitive role of neurogenesis in depression and antidepressant treatment.
Perera TD; Park S; Nemirovskaya Y
Neuroscientist; 2008 Aug; 14(4):326-38. PubMed ID: 18612087
[TBL] [Abstract][Full Text] [Related]
25. Regulation of adult hippocampal neurogenesis: relevance to depression.
Vaidya VA; Fernandes K; Jha S
Expert Rev Neurother; 2007 Jul; 7(7):853-64. PubMed ID: 17610392
[TBL] [Abstract][Full Text] [Related]
26. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
Tardito D; Perez J; Tiraboschi E; Musazzi L; Racagni G; Popoli M
Pharmacol Rev; 2006 Mar; 58(1):115-34. PubMed ID: 16507885
[TBL] [Abstract][Full Text] [Related]
27. Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats.
Kuramochi M; Nakamura S
Neuroscience; 2009 Sep; 163(1):448-55. PubMed ID: 19524023
[TBL] [Abstract][Full Text] [Related]
28. New views on antidepressant action.
Baudry A; Mouillet-Richard S; Launay JM; Kellermann O
Curr Opin Neurobiol; 2011 Dec; 21(6):858-65. PubMed ID: 21530233
[TBL] [Abstract][Full Text] [Related]
29. Long-term plasticity of visually evoked potentials in humans is altered in major depression.
Normann C; Schmitz D; Fürmaier A; Döing C; Bach M
Biol Psychiatry; 2007 Sep; 62(5):373-80. PubMed ID: 17240361
[TBL] [Abstract][Full Text] [Related]
30. Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells.
Kovaru H; Pav M; Kovaru F; Raboch J; Fiserova A
Neuro Endocrinol Lett; 2009; 30(4):421-8. PubMed ID: 20010506
[TBL] [Abstract][Full Text] [Related]
31. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.
Sairanen M; O'Leary OF; Knuuttila JE; Castrén E
Neuroscience; 2007 Jan; 144(1):368-74. PubMed ID: 17049169
[TBL] [Abstract][Full Text] [Related]
32. New insights into the mechanisms of antidepressant therapy.
Schloss P; Henn FA
Pharmacol Ther; 2004 Apr; 102(1):47-60. PubMed ID: 15056498
[TBL] [Abstract][Full Text] [Related]
33. Antistress properties of antidepressant drugs and their clinical implications.
Calabrese F; Molteni R; Riva MA
Pharmacol Ther; 2011 Oct; 132(1):39-56. PubMed ID: 21640755
[TBL] [Abstract][Full Text] [Related]
34. Synaptic plasticity and mood disorders.
Duman RS
Mol Psychiatry; 2002; 7 Suppl 1():S29-34. PubMed ID: 11986993
[TBL] [Abstract][Full Text] [Related]
35. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
Kozisek ME; Middlemas D; Bylund DB
Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide, stress, and depression.
McLeod TM; López-Figueroa AL; López-Figueroa MO
Psychopharmacol Bull; 2001; 35(1):24-41. PubMed ID: 12397868
[TBL] [Abstract][Full Text] [Related]
37. Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants.
Piser TM
Brain Behav Immun; 2010 May; 24(4):515-24. PubMed ID: 20193757
[TBL] [Abstract][Full Text] [Related]
38. [Biological vulnerability to depressive disorders].
Poirier-Littré MF
Encephale; 1994 Dec; 20 Spec No 4():629-38. PubMed ID: 7895629
[TBL] [Abstract][Full Text] [Related]
39. Neuroscience basis of clinical depression: implications for future antidepressant drug development.
Preskorn SH; Drevets WC
J Psychiatr Pract; 2009 Mar; 15(2):125-32. PubMed ID: 19339846
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain.
McEwen BS
Metabolism; 2005 May; 54(5 Suppl 1):20-3. PubMed ID: 15877308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
